In the third quarter of 2025, Mirador closed a $250 million Series B financing, bringing total capital raised to more than $650 million since the company launched in March 2024. The proceeds enable ...
“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...
The study, titled “Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis,” analyzed imaging and clinical data from 106 individuals with CF who were imaged and ...
Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...
Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance. Multidimensional ...
The treatment of chronic obstructive pulmonary disease (COPD) has been guided for decades by robust clinical practice guidelines (CPGs), such as NICE1 and GesEPOC,2 as well as international ...
Credit: Getty Images The 2026 GOLD COPD Update provides updated guidance on case-finding, disease activity, exacerbation management, and AI, as well as new criteria GOLD categories. The Global ...
I maintain a Hold rating on United Therapeutics, as it has risen steeply since my previous report because of exciting data from a recent trial. Pivotal data from United's IPF trial caused the market ...